Metformin mystery: does a common diabetes drug impact ICU survival?
NCT ID NCT07300293
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 100 adults with type 2 diabetes who were admitted to the ICU with severe lactic acidosis. Researchers want to see if taking metformin before admission affects their chances of survival. The goal is to better understand the role of this common diabetes drug in critical illness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Médecine Intensive - Réanimation - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?